Skip to content
Solar Spin Zone

Zimbabwe Turns Down ‘Unbalanced’ American Healthcare Assistance Package Because of Data Fears

Medical aid illustration
The offered American funding was intended for programmes for HIV/Aids treatment and prevention, tuberculosis, and malaria.

Zimbabwe has declined a major US healthcare agreement valued at $367m (£272m) over five years because of Washington's demand for confidential data.

This rejection became public after a government memo dated December was leaked, indicating that President Emmerson Mnangagwa believed the arrangement was "lopsided".

A government spokesperson has since explained that the United States was seeking biological samples for research and profit while refused to share the benefits from future medical innovations.

"We must now begin the challenging and unfortunate process of winding down our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the US had furnished over $1.9bn in health funding to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has appealed for more negotiations to reach a deal agreeable to all parties so the nation's vital HIV programme can continue.

Wider Background

This development comes after a similar situation in Kenya, where a court blocked a similar deal with the US after legal challenges were filed about the security of Kenyans' medical information.

After resuming the presidency last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.

The agency had managed assistance for the US government, but Trump argued its spending was "inefficient" and his government was pursuing direct bilateral deals to boost transparency and responsibility.

Based on reports, 16 African countries have so far signed similar health pacts, representing over $18.3bn in new funding.

Details of the Rejected Agreement

This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this cooperation could have provided immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy through US-supported programmes," Tremont commented.

However, official spokesman Nick Mangwana argued the proposed deal was "unfair".

"Zimbabwe was being asked to share its genetic material and health information over an extended period, without any equivalent promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," Mangwana explained.

"Effectively, our nation would supply the raw materials for medical research with no assurance that the end products would be accessible to our people should a future disease outbreak emerge."

National Interest and Global Health

Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were undermining frameworks previously set up through the global organization.

The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to deal with potential global health emergencies.

"This system is intended to ensure that when a country provides its data, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to create them."

Zimbabwe's reservations regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.

"We are open to further discussions with our US partners on how future co-operation could be structured in a manner that respects the sovereignty and dignity of both nations."

Health Experts Response

A leading public health body stated it recognised the official position, but recommended that negotiations need to persist given that a large portion of the nation's HIV programmes relied on external financing.

"Where specific concerns arise, including those involving data governance or agreement terms, these can frequently be resolved via detailed discussion and mutually agreed protections," the group commented.

The halted deal emphasises the continuing tensions between receiving vital foreign assistance and safeguarding national sovereignty in an increasingly data-driven world.

GE
Written by

Gwendolyn Erickson

Renewable energy journalist with a decade of experience covering solar innovations and sustainable technology trends worldwide.

Solar Spin Zone

Type to search articles.